IART · Integra Lifesciences Holdings Corp
$18.82
-0.19 (-1.00%)
At close · Jul 22
Market Cap
$1.46B
Shares
77.80M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| Investor Event Transcript | 2026-06-30 | — | |
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-05-08 | 2026-05-07 | |
| 8-K | 2026-05-05 | — | |
| 8-K | 2026-05-05 | 2026-04-30 | |
| 10-Q | 2026-05-05 | 2026-03-31 | |
| 8-K | 2026-04-15 | 2026-04-10 | |
| DEF 14A | 2026-04-06 | 2025-12-31 | |
| 10-K | 2026-02-26 | 2025-12-31 | |
| 8-K | 2026-02-26 | — | |
| 8-K | 2025-12-12 | 2025-12-11 | |
| 10-Q | 2025-10-30 | 2025-09-30 | |
| 8-K | 2025-10-30 | — | |
| 8-K | 2025-07-31 | — | |
| 10-Q | 2025-07-31 | 2025-06-30 | |
| 8-K | 2025-06-09 | 2025-06-06 | |
| 8-K | 2025-05-13 | 2025-05-09 | |
| 8-K | 2025-05-05 | — | |
| 10-Q | 2025-05-05 | 2025-03-31 | |
| DEF 14A | 2025-04-04 | 2024-12-31 | |
| 8-K | 2025-02-25 | — | |
| 10-K | 2025-02-25 | 2024-12-31 | |
| 8-K | 2025-01-06 | 2024-12-19 | |
| 8-K | 2024-12-17 | 2024-12-12 | |
| 10-Q | 2024-11-04 | 2024-09-30 | |
| 8-K | 2024-11-04 | — | |
| 8-K | 2024-11-04 | — | |
| 10-Q | 2024-07-29 | 2024-06-30 | |
| 8-K | 2024-07-29 | — | |
| 8-K | 2024-05-17 | 2024-05-16 | |
| 8-K | 2024-05-13 | 2024-05-09 | |
| 10-Q | 2024-05-06 | 2024-03-31 | |
| 8-K | 2024-05-06 | — | |
| DEF 14A | 2024-04-04 | 2023-12-31 | |
| 8-K | 2024-02-28 | — | |
| 8-K | 2024-02-28 | 2024-02-27 | |
| 10-K | 2024-02-28 | 2023-12-31 | |
| 8-K/A | 2024-02-27 | 2023-12-12 | |
| 8-K | 2023-12-20 | 2023-12-15 | |
| 8-K | 2023-12-13 | 2023-12-12 | |
| 8-K | 2023-12-13 | 2023-12-12 | |
| 8-K | 2023-10-25 | — | |
| 10-Q | 2023-10-25 | 2023-09-30 | |
| 8-K | 2023-08-16 | 2023-08-15 | |
| 8-K | 2023-07-27 | 2023-07-26 | |
| 10-Q | 2023-07-27 | 2023-06-30 | |
| 8-K | 2023-06-21 | — | |
| 8-K | 2023-05-23 | 2023-05-22 | |
| 8-K | 2023-05-16 | 2023-05-12 | |
| 10-Q | 2023-04-26 | 2023-03-31 |
Showing 1–50 of 121 filings
Key facts
CIK
917520
CUSIP
457985208
13F (30d)
28 filings
28 filers
Visit website
Investor relations